Health Equity Drives Small Molecule Strategy At Serna Bio

 
• By Lucie Ellis-Taitt

Serna Bio is using machine learning and RNA biology to create a platform for the discovery of small molecule modulators of RNA. The startup will seek fresh funding in 2024 and is on the hunt for creative biopharma partnerships.

small molecule
• Source: Shutterstock

More from C-Suite Speaks

More from Leadership